ArQule, Inc. (ARQL) financial statements (2020 and earlier)

Company profile

Business Address ONE WALL STREET
BURLINGTON, MA 01803
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 1004831395975
Cash and cash equivalents 192015141316
Short-term investments 802816254759
Receivables 6     
Prepaid expense 1     
Other undisclosed current assets  11121
Total current assets: 1064932396176
Noncurrent Assets
Property, plant and equipment 000001
Long-term investments and receivables     420
Long-term investments     420
Deposits noncurrent assets     01
Other noncurrent assets 000001
Other undisclosed noncurrent assets     (2)(1)
Total noncurrent assets: 0001223
TOTAL ASSETS: 1074932406398
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 1389678
Accounts payable 111000
Accrued liabilities 11111 
Employee-related liabilities 21222 
Other undisclosed accounts payable and accrued liabilities 855348
Debt 2    2
Deferred revenue and credits2 51111
Other undisclosed current liabilities     01
Total current liabilities: 15109111822
Noncurrent Liabilities
Long-term debt and lease obligation 1315    
Long-term debt, excluding current maturities 1315    
Liabilities, other than long-term debt  2  516
Deferred revenue and credits   516
Derivative instruments and hedges, liabilities  2    
Other undisclosed noncurrent liabilities      0
Total noncurrent liabilities: 1316  516
Total liabilities: 28269112338
Temporary equity, carrying amount  9    
Stockholders' equity
Stockholders' equity attributable to parent 791424294161
Common stock 111111
Additional paid in capital 626547528511508505
Accumulated other comprehensive income (loss) (0)(0)00(0)0
Accumulated deficit (548)(534)(505)(482)(468)(445)
Total stockholders' equity: 791424294161
TOTAL LIABILITIES AND EQUITY: 1074932406398

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Gross profit:     (1)(0)
Operating expenses (39)(27)(28)(25)(34)(41)
Other undisclosed operating income 26 5111116
Operating loss: (14)(27)(23)(14)(24)(25)
Nonoperating income (expense) (2)(1)0011
Investment income, nonoperating 100001
Other nonoperating income 21 010
Interest and debt expense (2)(2)  (0)(0)
Loss from continuing operations before equity method investments, income taxes: (17)(29)(23)(14)(23)(25)
Other undisclosed income from continuing operations before income taxes 10    
Net loss available to common stockholders, diluted: (15)(29)(23)(14)(23)(25)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss: (15)(29)(23)(14)(23)(25)
Comprehensive loss: (15)(29)(23)(14)(23)(25)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (0)(0)(0)0(0)(0)
Comprehensive loss, net of tax, attributable to parent: (16)(29)(23)(14)(23)(25)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: